Equip Your Practice, Support Your Patients – Skin Cancer Awareness Month in partnership with Melanoma UK.
Press Release – 2nd May 2022
Skin cancer is the most common cancer in the world. Every May marks the UK’s Skin Cancer Awareness Month, World Skin Cancer Month, and Melanoma Awareness Month.
Due to the impact of the global pandemic caused by Covid-19, there has been a large increase in waiting times for patients to see their physicians and resulting in the potential of huge numbers of life-threatening Melanomas not being diagnosed. Our chosen charity, Melanoma UK are taking the public on a journey to ‘find the missing Melanomas’. Aiming to increase awareness and education of melanoma and non-melanoma skin cancers, prevention and empowering the UK public to take charge of their skin health.
We’re not just sitting on the side lines; we’re partnering with Melanoma UK to improve the standard of care offered to patients. We will be donating 10 market leading DermLite dermatoscopes to Melanoma UK to be given out to primary care practices around the UK. These will include the best dermatoscope available in the world today, the DermLite DL4 as well as one of our most popular dermatoscopes, the DermLite DL200 Hybrid. Along with these scopes, we’ll be providing connection kits and training to the winning practices to ensure that practitioners are equipped to not only change lives but save lives. Patients will be able to nominate the practices they attend, but we’re also giving GPs the chance to nominate their own practices to be in with a chance to win one of these life changing medical devices.
To show patients and the UK public the power of dermatoscopes, we’re also sponsoring the Melanoma UK ‘on the road’ Skin Cancer Spot Check van. This will provide a safe and standardised free skin cancer screening programme to members of the UK public. This will be an extended campaign running beyond May but launches in Liverpool for 3 days on Friday 27th through to Sunday 29th May 2022. We’re delighted to be partnering with Melanoma UK to offer these services to the UK public throughout the year, not just in the month of May.
On board the van will be a skin cancer nurse specialist using our DermLite DL4 dermatoscope to provide free skin checks.
Our goal, in collaboration with Melanoma UK is to support more accurate patient diagnosis, helping patients to know what to look out for, and equipping them to challenge their GPs on why they should be using a dermatoscope.
Each year, approximately 147,000 new cases of non-melanoma skin cancers are diagnosed in the UK. That’s why early detection is so important, the earlier we catch life threatening melanomas, the higher the rate of survival. Utilising a dermatoscope can improve diagnosis accuracy up to 27% more compared to the naked eye.
Keep an eye out for what else we’ll be doing this month, including giving away free skin cancer rulers for you to help getting the right punch size for when skin biopsies are required. We’ll also be sharing information on why it’s vital for healthcare professionals to use dermatoscopes, how to help educate your patients about checking their skin and helping you to find the right dermatoscope for you and your practice.
To nominate your practice - click here
For any questions regarding this press release, please contact firstname.lastname@example.org
At Schuco we know the importance of identifying, diagnosing, and treating skin conditions for both healthcare professionals and for patients. Our products are designed to make this process easier for all those involved. We work across dermoscopy, total body skin imaging, electrosurgery, sutures, aesthetics, plastic surgery and more. If it concerns the largest organ in the body, then you need Schuco, experts in all things skin.
Since 1957 our customers have trusted us to offer unmatched customer experience, training, and support, combined with the most innovative products from around the world. We’re proud to change patient’s lives and most importantly, save lives.
www.schuco.co.uk / @SchucoUK
About Melanoma UK:
At Melanoma UK, we believe it is vital to proactively use evidence in our advocacy work.
An increasing proportion of patients are highly sophisticated in their research and understanding of evidence, and we are matching this movement. Examples include participation in health technology appraisal meetings (NICE and SMC), presenting clinically validated information on our website, authoring publications from our Melanoma UK digital registry, engaging with our own panel of medical experts, and using our registry data to support patient-centric initiatives, such as targeting travel grants where they are most needed.
Ultimately, all these initiatives are designed to benefit and support patients, which has been Melanoma UK's mission since its foundation.
www.melanomauk.org.uk / @MelanomaUK